Randy Seeley

Randy Seeley is the Henry King Ransom Endowed Professor of Surgery, Internal Medicine, and Nutritional Sciences at the University of Michigan School of Medicine. He directs the NIH-funded Michigan Nutrition Obesity Research Center (MNORC) and previously led the Cincinnati Diabetes and Obesity Center. His research focuses on the brain-gut axis in energy balance, GLP-1 agonists, and molecular mechanisms of bariatric surgery.

• Education: Ph.D. (University of Pennsylvania, 1993), B.A. (Grinnell College, 1989)
• Awards: Lilly Scientific Achievement Award (2003), Ernst Oppenheimer Award (2008), ADA Outstanding Scientific Achievement (2009)
• Collaborations: Over 390 peer-reviewed publications, industry partnerships with Novo Nordisk, Eli Lilly, and 48+ companies

His recent work spans neuroendocrinology, metabolic surgery, and hormonal therapies for obesity/diabetes. Key trends include GLP-1 receptor agonists, gut-brain communication, and FGF15/19 pathways. He serves as Senior Associate Editor for Diabetes and chairs NIH review panels.

• Scientific Awards
  • 2003 Lilly Scientific Achievement Award
  • 2008 Ernst Oppenheimer Award
  • 2009 ADA Outstanding Scientific Achievement

Current grants include NIH projects on intestinal Reg3g, GFRAL expression, and collaborations with Bullfrog AI, Glyscend, and Eli Lilly. His lab explores molecular targets for obesity/diabetes, with media recognition in New York Times and Wall Street Journal.